Callahan Advisors’s Steris STE Stock Holding History

Callahan Advisors’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.2M	Sell	45,914 -250	-0.5%	-$61.2K	0.85%	36
2025 Q4	$11.7M	Sell	46,164 -2,640	-5%	-$663K	0.96%	31
2025 Q3	$12.1M	Buy	48,804 +998	+2%	+$239K	1.03%	31
2025 Q2	$11.5M	Buy	47,806 +6,430	+16%	+$1.5M	1.03%	31
2025 Q1	$9.38M	Buy	41,376 +2,807	+7%	+$617K	0.89%	37
2024 Q4	$7.93M	Buy	38,569 +3,286	+9%	+$721K	0.75%	43
2024 Q3	$8.56M	Sell	35,283 -579	-2%	-$135K	0.83%	38
2024 Q2	$7.87M	Sell	35,862 -3,002	-8%	-$652K	0.82%	40
2024 Q1	$8.74M	Sell	38,864 -614	-2%	-$138K	0.92%	38
2023 Q4	$8.68M	Sell	39,478 -1,421	-3%	-$301K	1.01%	34
2023 Q3	$8.97M	Buy	40,899 +35	+0.1%	+$7.92K	1.13%	33
2023 Q2	$9.19M	Buy	40,864 +1,543	+4%	+$309K	1.12%	31
2023 Q1	$7.52M	Buy	39,321 +165	+0.4%	+$31.9K	0.97%	39
2022 Q4	$7.23M	Buy	39,156 +4,547	+13%	+$799K	0.99%	39
2022 Q3	$5.75M	Buy	34,609 +265	+0.8%	+$53.9K	0.83%	45
2022 Q2	$7.08M	Sell	34,344 -620	-2%	-$140K	0.94%	43
2022 Q1	$8.45M	Buy	34,964 +775	+2%	+$180K	0.96%	40
2021 Q4	$8.32M	Buy	34,189 +571	+2%	+$130K	0.93%	40
2021 Q3	$6.87M	Sell	33,618 -185	-0.5%	-$39.6K	0.87%	43
2021 Q2	$6.97M	Buy	33,803 +426	+1%	+$85.8K	0.89%	41
2021 Q1	$6.36M	Buy	33,377 +339	+1%	+$62.9K	0.86%	43
2020 Q4	$6.26M	Buy	33,038 +595	+2%	+$111K	0.92%	40
2020 Q3	$5.72M	Buy	32,443 +245	+0.8%	+$39.2K	0.93%	40
2020 Q2	$4.94M	Buy	32,198 +9,405	+41%	+$1.43M	0.88%	42
2020 Q1	$3.19M	Buy	22,793 +705	+3%	+$105K	0.67%	48
2019 Q4	$3.37M	Buy	22,088 +1,377	+7%	+$202K	0.54%	56
2019 Q3	$2.99M	Buy	20,711 +896	+5%	+$134K	0.52%	54
2019 Q2	$2.95M	Buy	19,815 +1,375	+7%	+$184K	0.53%	53
2019 Q1	$2.36M	Buy	18,440 +1,855	+11%	+$218K	0.44%	57
2018 Q4	$1.77M	Sell	16,585 -789	-5%	-$88.1K	0.38%	57
2018 Q3	$1.99M	Sell	17,374 -1,734	-9%	-$196K	0.37%	63
2018 Q2	$2.01M	Buy	19,108 +415	+2%	+$41.7K	0.4%	64
2018 Q1	$1.75M	Buy	18,693 +26	+0.1%	+$2.36K	0.36%	64
2017 Q4	$1.63M	Buy	18,667 +895	+5%	+$79.8K	0.32%	68
2017 Q3	$1.57M	Buy	17,772 +2,256	+15%	+$191K	0.33%	66
2017 Q2	$1.26M	Sell	15,516 -485	-3%	-$36.9K	0.28%	73
2017 Q1	$1.11M	Sell	16,001 -10,147	-39%	-$702K	0.25%	73
2016 Q4	$1.76M	Sell	26,148 -7,860	-23%	-$533K	0.42%	63
2016 Q3	$2.49M	Sell	34,008 -2,075	-6%	-$147K	0.62%	53
2016 Q2	$2.48M	Sell	36,083 -4,975	-12%	-$349K	0.65%	52
2016 Q1	$2.92M	Sell	41,058 -18,166	-31%	-$1.23M	0.8%	48
2015 Q4	$4.46M	Sell	59,224 -1,350	-2%	-$97.5K	1.27%	32
2015 Q3	$3.94M	Sell	60,574 -1,170	-2%	-$77.3K	1.21%	36
2015 Q2	$3.98M	Buy	61,744 +946	+2%	+$63.8K	1.15%	39
2015 Q1	$4.27M	Buy	60,798 +3,643	+6%	+$240K	1.25%	39
2014 Q4	$3.71M	Buy	57,155 +4,244	+8%	+$262K	1.09%	43
2014 Q3	$2.85M	Buy	52,911 +3,444	+7%	+$187K	0.88%	49
2014 Q2	$2.65M	Buy	49,467 +9,512	+24%	+$490K	0.84%	52
2014 Q1	$1.91M	Buy	39,955 +1,060	+3%	+$49.6K	0.65%	59
2013 Q4	$1.87M	Buy	38,895 +1,725	+5%	+$78.8K	0.65%	61
2013 Q3	$1.6M	Buy	37,170 +4,195	+13%	+$182K	0.61%	63
2013 Q2	$1.41M	Buy	+32,975	New	+$1.42M	0.58%	64

Other funds holding STE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Callahan Advisors's STE Position: Q1 2026 in Review

Callahan Advisors reduced its Steris (STE) stake by 0.54% in Q1 2026, selling an estimated $61.2K and leaving 45,914 shares worth $10.2M. The position accounts for 0.85% of the portfolio, ranked #36.

Callahan Advisors first reported a position in STE in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.1M in Q3 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

Callahan Advisors held 45,914 shares of Steris worth $10.2M as of Q1 2026.
Callahan Advisors sold 250 Steris shares in Q1 2026, an estimated $61.2K.
Steris made up 0.85% of Callahan Advisors's portfolio in Q1 2026, its #36 holding.
Callahan Advisors first reported a position in Steris in Q2 2013 and has held it in 52 quarters since.
Callahan Advisors's Steris position peaked at $12.1M in Q3 2025.
838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Callahan Advisors's 13F filing for Q1 2026, filed 12 May 2026.